Search terms
Results 1 - 10 of 63 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 7

Download PDF Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and the prescription of emerging lipid-lowering agents Current ...

Date : 08/07/2016

Catherine M Otto Correspondence to Professor Catherine M Otto, Division of Cardiology, University of Washington, Seattle, WA 98195, USA; cmotto{at} A major challenge in improving ...

Heart, Heartbeat, Catherine M Otto

Date : 15/05/2014

Implementation of statin therapy in practice for primary prevention of cardiovascular disease is controversial due to concerns over costs and side-effects with broader use and uncertainty regarding ...

Heart, JournalScan, Kate Kearney, James M McCabe

Date : 01/10/2016 Item size : 59671 bytes

Communications from regulators such as the US Food and Drug Administration concerning potential side effects of statin therapy (particularly memory loss and the risk of diabetes) have created debate ...

European Heart Journal, Clinical update, Muh Geot Wong, Christoph Wanner, John Knight, Vlado Perkovic

Date : 14/11/2015

Abstract Aims To compare the efficacy [low-density lipoprotein cholesterol (LDL-C) lowering] and safety of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin 9, ...

European Heart Journal, Coronary artery disease, Christopher P. Cannon, Bertrand Cariou, Dirk Blom, James M. McKenney, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun

Date : 14/05/2015

Abstract Aim We tested the hypothesis that statin-related news stories, cardiovascular disease, diabetes, statin dose, calendar year, and socio-demographic status are associated with early statin ...

European Heart Journal, CLINICAL RESEARCH, Sune Fallgaard Nielsen, Børge Grønne Nordestgaard

Date : 14/03/2016

In this regard there are two areas in which the American College of Cardiology/American Heart Association (ACC/AHA) 2013 guidelines and the European Society of Cardiology/European Atherosclerosis ...

European Heart Journal, Ray, Kausik K., Kastelein, John J. P.

Date : 21/02/2017 Item size : 94956 bytes

Aim We compared the 2013 American College of Cardiology/American Heart Association (ACC/AHA) and the 2016 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines on ...

European Heart Journal, Mortensen, Martin Bødtker, Nordestgaard, Børge G., Afzal, Shoaib, Falk, Erling

Date : 21/02/2017 Item size : 299217 bytes

B-mode ultrasound measurement of the carotid intima media thickness (cIMT) is the best validated imaging modality and most widely used surrogate endpoint in intervention studies to evaluate treatment ...

European Heart Journal, van der Valk, Fleurtje M., van Wijk, Diederik F., Stroes, Erik S. G.

Date : 01/12/2012 Item size : 148551 bytes

Allocation to rosuvastatin when compared with placebo was associated with a 27% reduction in the relative risk of developing AF during the trial period; specifically, AF was reported among 138 ...

European Heart Journal, Peña, Jessica M., MacFadyen, Jean, Glynn, Robert J., Ridker, Paul M

Date : 01/02/2012 Item size : 251353 bytes